Navigation Links
NCPA Statement on Florida Study About Prescription Drug Prices in Underserved Areas
Date:11/5/2008

ALEXANDRIA, Va., Nov. 5 /PRNewswire-USNewswire/ -- Health Service Online has published a study called "Variation in Drug Prices at Pharmacies: Are Drug Prices Higher in Poor Areas," by Walid F. Gellad. In response, Bruce T. Roberts, RPh, National Community Pharmacists Association (NCPA) executive vice president and CEO, issued the following statement.

"The study by Dr. Walid Gellad is helpful in raising awareness about the variation in prescription drug prices between wealthier and poorer neighborhoods in Florida, but unfortunately misses the mark in many ways. For example, more than 90 percent of prescription drug prices are set by large pharmacy benefit managers (PBMs) with no ability for community pharmacies to negotiate, so these small businesses literally can't influence what their patients pay. In addition, underserved and rural communities often have a higher percentage of Medicaid and Medicare patients, making the number of cash prescriptions minimal. On a related note, using 'U&C' (usual and customary) as the data point for measuring cash pricing in the study is antiquated. In reality, U&C was an appropriate indicator decades ago when the majority of prescriptions were paid by cash; however that's now the exception rather than the rule."

"However, the study highlights one very important concern--the lack of access to a community pharmacy in rural and underserved areas. Large drugstore chains sometimes avoid these areas due to profitability concerns, often leaving pharmacy small business owners as the last hope for fulfilling the medications needs in these areas. Unfortunately, take-it-or-leave-it PBM contracts in Florida have resulted in no retail pharmacy presence in 74 ZIP codes where the median income is under $30,000, representing slightly over 185,000 people. This dynamic needs to be remedied."

"The best solution for helping those living in underserved neighborhoods is to allow community pharmacy owners to have good faith business negotiations with Wall Street's giant PBMs as is the case with the companion bills pending in the U.S. Congress - H.R. 971 and S. 2161. Fair contracts would allow more community pharmacies to operate and ensure patients have the medication access they need to stay healthy."

For a more comprehensive analysis of the study by NCPA, please go to the following link: http://www.ncpanet.org/pdf/drugpricesstudy.pdf

The National Community Pharmacists Association, founded in 1898, represents the nation's community pharmacists, including the owners of more than 23,000 pharmacies. The nation's independent pharmacies, independent pharmacy franchises, and independent chains dispense nearly half of the nation's retail prescription medicines. To learn more go to http://www.ncpanet.org.


'/>"/>
SOURCE National Community Pharmacists Association
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
2. Takeda statement on ACTOS meta-analysis published in the Journal of the American Medical Association
3. Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
4. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
5. Statement by Oscar S. Wyatt, Jr.
6. Statement from Employment Policies Institute on Senator Hillary Clintons Health Care Plan
7. Pelosi Statement on Proposed Entitlement Task Force
8. Statement by Robert Greenstein, Executive Director of the Center on Budget and Policy Priorities, on the New Congressional SCHIP Agreement
9. Statement on House/Senate Agreement on SCHIP Legislation
10. Statement from the Alliance for Quality Nursing Home Care
11. Produce for Better Health Foundation Releases Statement on Study Saying Fruit & Vegetable Consumption Not Strongly Associated With Colon Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... , ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... name the Creator responds to and which He does not. Yisrayl says with so ... one is the true name, but he says with a little Scripture, backed with a ...
(Date:4/28/2017)... ... April 28, 2017 , ... Phytomer USA ... region. Côté has 20+ years of experience within the beauty industry, ranging from ... an array of high-end cosmetic brands, retail brands and outlets in Canada and ...
(Date:4/28/2017)... ... April 28, 2017 , ... Woolsy Corporation ... supplements, through its Nova Skin Sciences division, recently announced the launch of Allumière ... with the power of an anti-aging concentrate. , Anogeissus Leiocarpa Bark ...
(Date:4/28/2017)... ... ... Rob Lowe is a popular actor that has been in many different movies ... as the host of the “Informed” series. The program focuses on many important issues ... focuses on thyroid cancer. , Although thyroid cancer is an uncommon type of cancer, ...
(Date:4/28/2017)... ... April 28, 2017 , ... Christie Medical Holdings, Inc. ... alliance with B. Braun Medical Inc. , a leader in infusion therapy and ... with as many as 90 percent of hospital patients receiving a peripheral IV catheter ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  RXi Pharmaceuticals ... innovative therapeutics that address significant unmet medical needs, ... from the Company,s consumer product development program, based ... the Society for Investigative Dermatology (SID) 76 th ... advance and promote the sciences relevant to skin ...
(Date:4/20/2017)... BOSTON , April 20, 2017   ZappRx, Inc ... the specialty drug prescribing process, today announced it closed $25 ... Fund, a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included ... A round in 2014, and GV (formerly Google ...
(Date:4/20/2017)... 20, 2017 Eyevensys, a private ... non-viral gene expression technology that enables the safe, local, ... address a wide range of ophthalmic diseases, announces it ... products Regulatory Agency (MHRA) to advance its technology into ... ...
Breaking Medicine Technology: